Neuro-Oncology · 2014 · 131 citations · 32 references
MedicineGeneticsOncologyCytogeneticsMolecular OncologyNeuro-oncologyBrain TumorsCancer CytogeneticsMolecular Classification Of TumorsMolecular Tumor ProfilingTumor ClassificationTumor GradingComplex KaryotypesCytogenetic Risk StratificationDna In Situ HybridizationMeningioma RecurrencePrognostic VariablesSingle Nucleotide Polymorphism ArraysStratificationTumor Localization
BACKGROUND: Tumor recurrence remains the major clinical complication of meningiomas, the majority of recurrences occurring among WHO grade I/benign tumors. In the present study, we propose a new scoring system for the prognostic stratification of meningioma patients based on analysis of a large series of meningiomas followed for a median of >5 years. METHODS: Tumor cytogenetics were systematically investigated by interphase fluorescence in situ hybridization in 302 meningioma samples, and the proposed classification was further validated in an independent series of cases (n = 132) analyzed by high-density (500K) single-nucleotide polymorphism (SNP) arrays. RESULTS: Overall, we found an adverse impact on patient relapse-free survival (RFS) for males, presence of brain edema, younger patients (<55 years), tumor size >50 mm, tumor localization at intraventricular and anterior cranial base areas, WHO grade II/III meningiomas, and complex karyotypes; the latter 5 variables showed an independent predictive value in multivariate analysis. Based on these parameters, a prognostic score was established for each individual case, and patients were stratified into 4 risk categories with significantly different (P < .001) outcomes. These included a good prognosis group, consisting of approximately 20% of cases, that showed a RFS of 100% ± 0% at 10 years and a very poor-prognosis group with a RFS rate of 0% ± 0% at 10 years. The prognostic impact of the scoring system proposed here was also retained when WHO grade I cases were considered separately (P < .001). CONCLUSIONS: Based on this risk-stratification classification, different strategies may be adopted for follow-up, and eventually also for treatment, of meningioma patients at different risks for relapse.
32
Arie Perry, Scott L. Stafford, B. W. Scheithauer et al. · The American Journal of Surgical Pathology · 1997 · 628 citations
Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases
Lucio Palma, Paolo Celli, Carmine Franco et al. · Journal of neurosurgery · 1997 · 315 citations
Impaired survival and long-term neurological problems in benign meningioma
Hanna van Alkemade, Michelle de Leau, Edith Dieleman et al. · Neuro-Oncology · 2012 · 235 citations · Full text
Anatomic location is a risk factor for atypical and malignant meningiomas
Ari J. Kane, Michael E. Sughrue, Martin J. Rutkowski et al. · Cancer · 2010 · 208 citations · Full text